Investigating the Effectiveness of 2 Different Doses of BIOHM FX Probiotic Blend in Improving Digestive Symptoms

Active, not recruitingOBSERVATIONAL
Enrollment

141

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

January 8, 2025

Study Completion Date

March 4, 2025

Conditions
Moderate Gastrointestinal Discomfort
Interventions
DIETARY_SUPPLEMENT

BIOHM FX Probiotic Blend

BIOHM Health has been selling BIOHM FX, a blend of probiotics as a dietary supplement addressed at the digestive health market since 2017. The blend is present in the market in various concentrations ranging from 30 Billion CFU to 1 Billion CFU. The probiotic blend consists of Lactobacillus acidophilus, Lactobacillus rhamnosus, Saccharomyces boulardii, Bifidobacterium breve and amylase. The blend is manufactured at cGMP facilities located in the United States and has attained self GRAS status. Prior to release, each lot of probiotic blend is tested for heavy metals, objectionable organisms, water content, probiotic potency, enzyme activity level and allergens, Soy, Milk and Gluten. Additionally, BIOHM performs annual testing for a full FALCPA panel of allergens ensuring there are no allergens present in the blend.

Trial Locations (1)

90034

People Science, Inc., Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

People Science, Inc.

INDUSTRY

lead

Biohm Technologies

INDUSTRY